Imricor Medical Systems Inc
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include… Read more
Imricor Medical Systems Inc (IMR) - Net Assets
Latest net assets as of June 2025: AU$23.08 Million AUD
Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has net assets worth AU$23.08 Million AUD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$55.57 Million) and total liabilities (AU$32.49 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$23.08 Million |
| % of Total Assets | 41.54% |
| Annual Growth Rate | N/A |
| 5-Year Change | -125.6% |
| 10-Year Change | N/A |
| Growth Volatility | 172.99 |
Imricor Medical Systems Inc - Net Assets Trend (2016–2024)
This chart illustrates how Imricor Medical Systems Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Imricor Medical Systems Inc (2016–2024)
The table below shows the annual net assets of Imricor Medical Systems Inc from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | AU$-7.38 Million | +15.72% |
| 2023-12-31 | AU$-8.75 Million | -216.55% |
| 2022-12-31 | AU$7.51 Million | -66.47% |
| 2021-12-31 | AU$22.40 Million | -22.26% |
| 2020-12-31 | AU$28.82 Million | +309.70% |
| 2019-12-31 | AU$7.03 Million | -47.78% |
| 2018-12-31 | AU$13.47 Million | +356.44% |
| 2017-12-31 | AU$-5.25 Million | -30.31% |
| 2016-12-31 | AU$-4.03 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Imricor Medical Systems Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11499930100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$27.02K | % |
| Other Components | AU$134.88 Million | % |
| Total Equity | AU$-7.38 Million | 100.00% |
Imricor Medical Systems Inc Competitors by Market Cap
The table below lists competitors of Imricor Medical Systems Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dap Gayrimenkul Gelistirme AS
IS:DAPGM
|
$322.10 Million |
|
Auto Partner SA
WAR:APR
|
$322.12 Million |
|
China Western Power Industrial Co Ltd
SHE:002630
|
$322.20 Million |
|
Fujian Forecam Optics Co Ltd
SHG:688010
|
$322.32 Million |
|
Star Gas Partners LP
NYSE:SGU
|
$321.94 Million |
|
Kopin Corporation
NASDAQ:KOPN
|
$321.91 Million |
|
Omnijoi Media Corp
SHE:300528
|
$321.90 Million |
|
Van Phu - Invest Investment JSC
VN:VPI
|
$321.83 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Imricor Medical Systems Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -12,828,267 to -7,377,033, a change of 5,451,234.
- Net loss of 29,692,831 reduced equity.
- Share repurchases of 1,905,897 reduced equity.
- New share issuances of 32,906,291 increased equity.
- Other factors increased equity by 4,143,671.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-29.69 Million | -402.5% |
| Share Repurchases | AU$1.91 Million | -25.84% |
| Share Issuances | AU$32.91 Million | +446.06% |
| Other Changes | AU$4.14 Million | +56.17% |
| Total Change | AU$- | % |
Book Value vs Market Value Analysis
This analysis compares Imricor Medical Systems Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | AU$-0.04 | AU$1.89 | x |
| 2017-12-31 | AU$-0.05 | AU$1.89 | x |
| 2018-12-31 | AU$0.14 | AU$1.89 | x |
| 2019-12-31 | AU$0.07 | AU$1.89 | x |
| 2020-12-31 | AU$0.25 | AU$1.89 | x |
| 2021-12-31 | AU$0.17 | AU$1.89 | x |
| 2022-12-31 | AU$0.05 | AU$1.89 | x |
| 2023-12-31 | AU$-0.08 | AU$1.89 | x |
| 2024-12-31 | AU$-0.03 | AU$1.89 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Imricor Medical Systems Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3094.86%
- • Asset Turnover: 0.04x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-70.58%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | -780.61% | 0.20x | 0.00x | AU$-5.09 Million |
| 2017 | 0.00% | -1186.48% | 0.19x | 0.00x | AU$-6.19 Million |
| 2018 | -54.18% | -543.52% | 0.08x | 1.19x | AU$-8.64 Million |
| 2019 | -210.40% | -2313.28% | 0.06x | 1.50x | AU$-15.50 Million |
| 2020 | -45.38% | -1862.37% | 0.02x | 1.16x | AU$-15.96 Million |
| 2021 | -91.77% | -2952.33% | 0.03x | 1.20x | AU$-22.80 Million |
| 2022 | -233.46% | -2148.77% | 0.06x | 1.82x | AU$-18.29 Million |
| 2023 | 0.00% | -3675.61% | 0.07x | 0.00x | AU$-21.34 Million |
| 2024 | 0.00% | -3094.86% | 0.04x | 0.00x | AU$-28.96 Million |
Industry Comparison
This section compares Imricor Medical Systems Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $14,750,885
- Average return on equity (ROE) among peers: -315.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Imricor Medical Systems Inc (IMR) | AU$23.08 Million | 0.00% | 1.41x | $321.96 Million |
| 4DMEDICAL Ltd (4DX) | $926.64K | -85.93% | 0.18x | $1.03 Billion |
| Adherium Ltd (ADR) | $34.53 Million | -3.63% | 0.08x | $2.37 Million |
| Aroa Biosurgery Ltd (ARX) | $-22.65 Million | 0.00% | 0.00x | $92.74 Million |
| Atomo Diagnostics Ltd (AT1) | $34.48 Million | -26.73% | 0.05x | $8.96 Million |
| Control Bionics Ltd (CBL) | $6.09 Million | -15.97% | 0.04x | $4.98 Million |
| Cardiex Ltd (CDX) | $3.03 Million | -101.61% | 0.73x | $4.25 Million |
| Compumedics Ltd (CMP) | $9.21 Million | -30.70% | 1.16x | $13.08 Million |
| Cochlear Ltd (COH) | $75.42 Million | 53.19% | 1.13x | $7.01 Billion |
| Cleo Diagnostics Ltd (COV) | $5.83 Million | -68.54% | 0.19x | $23.47 Million |
| Conneqt Health Limited (CQT) | $633.50K | -2871.98% | 13.72x | $4.66 Million |